CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...

The model was initially launched by the Biden administration in February 2023, and CMS announced that SCD would be the first focus of the model the following January. This is the ...

RC: Sickle cell disease is an inherited disorder.It’s not one that you acquire later in life or due to any other reason. You get one affected gene from each parent and that’s why there are ...

Sickle cell disease (SCD) is a group of genetic blood disorders. A person inherits SCD from their parents when they inherit two copies of the sickle cell gene, one from each parent.

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

A cure for sickle cell anemia and other life-threatening genetic disorders that arise in the blood is the goal of a new $6.7-million, five-year research project headed by UCSF scientist Y. W. Kan, a ...

The Centers for Medicare and Medicaid Services (CMS) has selected 35 participants for its new, voluntary Cell and Gene ...

Sickle cell trait evolved as protection against malaria, especially in tropical regions. Its discovery advanced understanding of genetic inheritance, but racial bias long hindered care for affected ...

Families of those who have sickle cell disease in the Philadelphia area are pushing for more research and a cure.

Sickle cell disease is an extremely debilitating condition that affects up to 40% of the population in African countries, with patients suffering episodes of excruciating pain, organ damage and ...